SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CLTR COULTER PHARMACEUTICAL
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
666 17 0 CLTR
Emcee:  HARRY GIBSON Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
566 Ron, I was being facious. I am not interested in rumors. This has been a very hVector1-4/27/2000
565 I see... So now you're the thread censor, are you? Care to share who granHawkmoon-4/27/2000
564 "Rumour has it that a particular drug with the above mentioned storage reqceleryroot.com-4/26/2000
563 <i>Heard any rumors as to when the filing will occur.</i> Now thatHawkmoon-4/26/2000
562 Ron, Where have you been. Bexxar has published awesome results. The Fludarbine Vector1-4/26/2000
561 Tom, What? You want me to come right out and name my source? Call it heHawkmoon-4/26/2000
560 Rumour? That's it?tom pope-4/26/2000
559 If Bexxar is the drug that comes in powder form that must be kept refrigerated Hawkmoon-4/26/2000
558 Maybe this answers how SKB really feels about Coulter and Bexxar. Wednesday ApBob L-4/26/2000
557 <Why would SKB give up these rights?> Rights AND obligtions. Difficult tRWReeves-4/25/2000
556 Peter, True, except that ROW did not include Japan under the original agreemenbiowa-4/25/2000
555 biowa, <i>There is a clause that if SKB doesn't begin "construcBiomaven-4/25/2000
554 It has been 239 days since we found out that the FDA wanted the data reformatteGregSL-4/25/2000
553 Brian, <i>Why not say that it was due to SKB's non-action in the PR?biowa-4/25/2000
552 Biowa: Thanks for the response. I hope that more details are released soon. Micawber-4/25/2000
551 Biowa, Very good research. J.D.jayhawk969-4/25/2000
550 Brian, Actually, it appears that this was anticipated in the original agreemenbiowa-4/25/2000
549 RWR: Buying op or falling knife? I've seen so many of these "reacquiMicawber-4/25/2000
548 Looks like a buy op. in CLTR this morning. Missed the cheapest but back in hereRWReeves-4/25/2000
547 Coulter Pharmaceutical Reacquires Rights to Bexxar Outside of the U.S. from SmiGeoDude-4/25/2000
546 April 25, 2000--Coulter Pharmaceutical (Nasdaq:CLTR - news) and SmithKline Beecnigel bates-4/25/2000
545 News is irrelevant. Resistance is futile. Your dollars will be assimilated. Bob L-4/5/2000
544 RB - You are correct. Toth's long (mid?) term outlook has not changed: <Cheryl Galt-3/29/2000
543 Bob and Cheryl, Thank you for the clarification. Mainly, I was concerned thatRussian Bear-3/29/2000
542 The 3-page 3/29 Prudential report is free at Multex Investor. multexinvestor.coCheryl Galt-3/29/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News